Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?-Reference-Cited by-同舟云学术

Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?

Published:2010-08-23 Issue:8 Volume:5 Page:e12329
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Durrmeyer Xavier,Hovhannisyan Shushanik,Médard Yves,Jacqz-Aigrain Evelyne,Decobert Fabrice,Barre Jérome,Alberti Corinne,Aujard Yannick,Danan Claude,Baud Olivier

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Comparative tolerability of pharmacological treatments for patent ductus arteriosus.;C Hammerman;Drug Saf,2001

2. Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g.;T Trus;J Pediatr Surg,1993

3. Management of patent ductus arteriosus: A comparison of operative v pharmacologic treatment.;SB Palder;J Pediatr Surg,1987

4. Prophylactic indomethacin: Factors determining permanent ductus arteriosus closure.;M Narayanan;J Pediatr,2000

5. Patent ductus arteriosus: Evidence for and against treatment.;RI Clyman;J Pediatr,2007

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patent Ductus Arteriosus in the Preterm Infant;Avery's Diseases of the Newborn;2024

2. Impact of Pharmacogenomics in Clinical Practice;Pharmaceuticals;2023-11-13

3. Association of patent ductus arteriosus with fetal factors and endotypes of prematurity;Seminars in Perinatology;2023-03

4. Racial disparities in the development of comorbid conditions after preterm birth: A narrative review;Seminars in Perinatology;2022-12

5. The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review;Pharmacogenomics and Personalized Medicine;2022-06